cyc 202 has been researched along with Diabetes Mellitus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, JJ; Li, XH; Li, Y; Wang, Y; Xiang, Q; Yao, YH | 1 |
| Boucher, J; Harms, M; Maurer, S | 1 |
1 review(s) available for cyc 202 and Diabetes Mellitus
| Article | Year |
|---|---|
The colorful versatility of adipocytes: white-to-brown transdifferentiation and its therapeutic potential in humans.
Topics: Acetanilides; Adipocytes, Beige; Adipocytes, Brown; Adipocytes, White; Adipose Tissue, Brown; Adipose Tissue, White; Animals; Cell Lineage; Cell Transdifferentiation; Diabetes Mellitus; Drugs, Investigational; Energy Metabolism; Humans; Imatinib Mesylate; Obesity; Roscovitine; Thermogenesis; Thiazoles | 2021 |
1 other study(ies) available for cyc 202 and Diabetes Mellitus
| Article | Year |
|---|---|
Inactivated AMPK-α2 promotes the progression of diabetic brain damage by Cdk5 phosphorylation at Thr485 site.
Topics: AMP-Activated Protein Kinases; Animals; Cell Line; Cyclin-Dependent Kinase 5; Diabetes Mellitus; HEK293 Cells; Hippocampus; Humans; Male; Metformin; Mice; Neurons; Rats; Roscovitine | 2020 |